Pancreas-on-a-chip technology to aid in diabetes research
Scientists combine organ-on-a-chip and stem-cell technologies to make a powerful tool for diabetes research.
List view / Grid view
Scientists combine organ-on-a-chip and stem-cell technologies to make a powerful tool for diabetes research.
Researchers have developed a new AI system which was able to discover and then successfully test several new compounds within 46 days.
New lab on a chip technology has been developed to evaluate the effects of different drivers of NAFLD on liver cells.
AI has applications in many areas of research, including genomics. Slavé Petrovski of AstraZeneca reveals how AI is used in the study of the human genome and how it may evolve in the future.
New computer model that simulates the way red blood cells become misshapen by sickle cell disease could identity promising drug candidates.
Claus Bendtsen at AstraZeneca reveals how AI can be used to improve our understanding of disease, to help identify the causes of conditions and aid in drug discovery.
Researchers may have fundamentally altered the way scientists study brain diseases with new CRISPR technology.
Researchers hope the system can choose the right patients to enroll in clinical trials, to speed discovery of drug treatments.
CD4+ T-cells play a central role in directing adaptive immune responses against invading microbial pathogens.
Sartorius debuts their new product, the Intellicyt iQue3, at this year's CYTO® conference and exhibition.
Mosaic Sample Management is Titian Software’s comprehensive, customisable, modular software product to control and monitor all aspects of sample storage, preparation and delivery.
Unique considerations surrounding the bureaucracy and oversight in the use of human biospecimens in the European Union.
A new AI project marks the first time 10 pharmaceutical companies have agreed to share data to aid drug discovery.
Nuclear magnetic resonance measurement and state-of-the-art computational science reveal protein structures in higher eukaryotic cells.
A new report reveals a thriving service and supply sector for the UK in addition to its research and development biotechs.